Name: Acinetobacter baumannii 2208
Creator: BacDive
License: http://creativecommons.org/licenses/by-nc/4.0/

Strain identifier

BacDive ID: 8093

Type strain:

Species: Acinetobacter baumannii

Strain Designation: 2208, 81

Culture col. no.: DSM 30007, ATCC 19606, CIP 70.34, DSM 6974, JCM 6841, CCUG 19096, CGMCC 1.6769, IAM 12088, KCTC 2508, LMG 1041, LMG 10545, NBRC 109757, NCIMB 12457, NCTC 12156

Strain history: CIP <- 1970, M. Piéchaud, Inst. Pasteur, Paris, France, Moraxella glucidolytica var. nonliquefaciens <- 1969, ATCC, Achromobacter anitratum <- R. Hugh: strain 2208 <- E.O. King <- I.G. Schaub: strain 81

NCBI tax ID(s): 575584 (strain), 470 (species)

SI-ID 92085

LMG 1041, ATCC 19606, CCUG 19096, DSM 30007, IAM 12088, LMG 10545, NCIMB 12457, NCTC 12156, DSM 6974, NCIB 12457, JCM 6841, LMD 85.21, KCTC 2508, NCCB 85021, NCCB 96002, LMD 96.2, NCCB 96128, LMD 96.128, BCRC 10591, CCRC 10591, NCAIM B.01930, CIP 7034, NCAIM B.02074, CNCTC 6168, VTT E-981116, CIP 70.34

Other strains from Acinetobacter baumannii

Section

Acinetobacter baumannii 2208 is an obligate aerobe, mesophilic, Gram-negative bacterium that has multiple antibiotic resistances and was isolated from urine.

antibiotic resistance
Gram-negative
mesophilic
obligate aerobe
16S sequence
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	14-12-2023 (DD-MM-YYYY)
	Domain	"Bacteria"
	Phylum	*Pseudomonadota*
	Class	*Gammaproteobacteria*
	Order	*Pseudomonadales*
	Family	*Moraxellaceae*
	Genus	*Acinetobacter*
	Species	**Acinetobacter baumannii**
	Full Scientific Name (LPSN)	Acinetobacter baumannii Bouvet and Grimont 1986

Information on morphological and physiological properties Morphology

[Ref.: #116742]	Gram stain	negative
[Ref.: #69480]	Gram stain	negative Confidence in %99.996

[Ref.: #116742]	Cell shape	oval-shaped

[Ref.: #116742]	Motility	no

[Ref.: #9084]	Type of hemolysis	gamma
[Ref.: #9084]	Incubation period	1-2 days

Information on culture and growth conditions Culture and growth conditions

[Ref.: #9084]

Culture medium

COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)

[Ref.: #9084]

Culture medium growth

[Ref.: #9084]

Culture medium link

Medium recipe at MediaDive

[Ref.: #9084]

Culture medium composition

expand / minimize

[Ref.: #9084]

Culture medium

NUTRIENT AGAR (DSMZ Medium 1)

[Ref.: #9084]

Culture medium growth

[Ref.: #9084]

Culture medium link

Medium recipe at MediaDive

[Ref.: #9084]

Culture medium composition

expand / minimize

[Ref.: #42141]

Culture medium

MEDIUM 72- for trypto casein soja agar

[Ref.: #42141]

Culture medium growth

[Ref.: #42141]

Culture medium composition

expand / minimize

[Ref.: #9084]

Culture medium

TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)

[Ref.: #9084]

Culture medium growth

[Ref.: #9084]

Culture medium link

Medium recipe at MediaDive

[Ref.: #9084]

Culture medium composition

expand / minimize

[Ref.: #116742]

Culture medium

CIP Medium 72

[Ref.: #116742]

Culture medium growth

[Ref.: #116742]

Culture medium link

Medium recipe provided by DSMZ

	Kind of temperature		Temperature
[Ref.: #9084]		growth	30 °C
[Ref.: #9084]		growth	37 °C
[Ref.: #42141]		growth	30 °C
[Ref.: #67770]		growth	37 °C
[Ref.: #116742]		growth	22-44 °C
[Ref.: #116742]	no	growth	10 °C

[Ref.: #9084]	Temperature range	mesophilic
[Ref.: #42141]	Temperature range	mesophilic
[Ref.: #67770]	Temperature range	mesophilic
[Ref.: #116742]	Temperature range	psychrophilic

Information on physiology and metabolism Physiology and metabolism

[Ref.: #116742]

Oxygen tolerance

obligate aerobe

Note that the displayed test results represent raw data and therefore may deviate!

Antibiotic susceptibility testing

Test 1

Test 2

Reference

[Ref.: #9084]
Mueller-Hinton Agar
30
1
aerob
yes
Inhibition zone diameter in mm
resistant0
resistant0
resistant0
22
10-12
resistant0
resistant0
12
10
32-34
24
6-8
14
20-22
resistant0
12
resistant0
26-28
18
16
resistant0
6
resistant0
16
24
18-20
30
12-14
resistant0
12
28
resistant0
resistant0
resistant0
resistant0
24

[Ref.: #9084]
Mueller Hinton
30

aerob
yes
Inhibition zone diameter in mm
resistant0
resistant0
resistant0
24
10
resistant0
resistant0
10-12
8-10
36
24
resistant0
16
22
resistant0
10
resistant0
26
16
16
resistant0
6
resistant0
18
24
20
30
12-14
resistant0
8-10
28
resistant0
resistant0
resistant0
resistant0
24

Only first 15 entries are displayed. Click here to see all.

[Ref.: #69481]	Ability of spore formation	no Confidence in %100
[Ref.: #69480]	Ability of spore formation	no Confidence in %99.994

[Ref.: #9084]

Name of produced compound

siderophore acinetobactin

	Salt	Tested relation		Salt conc.
[Ref.: #116742]	NaCl		growth	0-4	%
[Ref.: #116742]	NaCl	no	growth	6	%
[Ref.: #116742]	NaCl	no	growth	8	%
[Ref.: #116742]	NaCl	no	growth	10	%

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68369]	adipate ChEBI	+	assimilation	* from API 20NE
[Ref.: #68371]	amygdalin ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	arbutin ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68369]	arginine ChEBI	-	hydrolysis	* from API 20NE
[Ref.: #68371]	cellobiose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-arabinose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-arabitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-fructose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-fucose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-galactose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-glucose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-lyxose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68369]	D-mannitol ChEBI	-	assimilation	* from API 20NE
[Ref.: #68371]	D-mannitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68369]	D-mannose ChEBI	-	assimilation	* from API 20NE
[Ref.: #68371]	D-mannose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-ribose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-sorbitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-tagatose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-xylose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68369]	decanoate ChEBI	+	assimilation	* from API 20NE
[Ref.: #68371]	erythritol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	esculin ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68369]	esculin ChEBI	-	hydrolysis	* from API 20NE
[Ref.: #68371]	galactitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	gentiobiose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68369]	gluconate ChEBI	-	assimilation	* from API 20NE
[Ref.: #68371]	gluconate ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #116742]	glucose ChEBI	+/-	degradation
[Ref.: #68371]	glycerol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	glycogen ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	inulin ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68369]	L-arabinose ChEBI	+	assimilation	* from API 20NE
[Ref.: #68371]	L-arabinose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-arabitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-fucose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-rhamnose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-sorbose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-xylose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	lactose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68369]	malate ChEBI	+	assimilation	* from API 20NE
[Ref.: #68369]	maltose ChEBI	-	assimilation	* from API 20NE
[Ref.: #68371]	maltose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	melezitose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	melibiose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	methyl alpha-D-glucopyranoside ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	methyl alpha-D-mannoside ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	methyl beta-D-xylopyranoside ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	myo-inositol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68369]	N-acetylglucosamine ChEBI	-	assimilation	* from API 20NE
[Ref.: #68371]	N-acetylglucosamine ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #116742]	nitrate ChEBI	-	reduction
[Ref.: #116742]	nitrate ChEBI	-	respiration
[Ref.: #68369]	nitrate ChEBI	-	reduction	* from API 20NE
[Ref.: #116742]	nitrite ChEBI	-	reduction
[Ref.: #68371]	Potassium 2-ketogluconate ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	Potassium 5-ketogluconate ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	raffinose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	ribitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	salicin ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	starch ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	sucrose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	trehalose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68369]	tryptophan ChEBI	-	energy source	* from API 20NE
[Ref.: #68371]	turanose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68369]	urea ChEBI	-	hydrolysis	* from API 20NE
[Ref.: #68371]	xylitol ChEBI	-	builds acid from	* from API 50CH acid
	Only first 10 entries are displayed. Click here to see all.

	Antibiotica	Metabolite	Antibiotic sensitivity	Antibiotic resistance
[Ref.: #116742]		0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate)	no	yes

	Metabolite production	Metabolite	Production
[Ref.: #116742]		indole ChEBI	no
[Ref.: #68369]		indole ChEBI	no	* from API 20NE

	Metabolite	Voges-Proskauer-test	Methylred-test	Indole test
[Ref.: #116742]	acetoin ChEBI	-
[Ref.: #116742]	glucose ChEBI		+
[Ref.: #68369]	indole ChEBI			-	* from API 20NE

	Enzyme	Enzyme activity	EC number
[Ref.: #68382]	acid phosphatase	+	3.1.3.2	* from API zym
[Ref.: #68382]	alkaline phosphatase	+	3.1.3.1	* from API zym
[Ref.: #68382]	alpha-chymotrypsin	-	3.4.21.1	* from API zym
[Ref.: #68382]	alpha-fucosidase	-	3.2.1.51	* from API zym
[Ref.: #68382]	alpha-galactosidase	-	3.2.1.22	* from API zym
[Ref.: #68382]	alpha-glucosidase	-	3.2.1.20	* from API zym
[Ref.: #68382]	alpha-mannosidase	-	3.2.1.24	* from API zym
[Ref.: #68369]	arginine dihydrolase	-	3.5.3.6	* from API 20NE
[Ref.: #116742]	beta-galactosidase	-	3.2.1.23
[Ref.: #68382]	beta-galactosidase	-	3.2.1.23	* from API zym
[Ref.: #68369]	beta-glucosidase	-	3.2.1.21	* from API 20NE, API zym
[Ref.: #68382]	beta-glucuronidase	-	3.2.1.31	* from API zym
[Ref.: #9084]	catalase	+	1.11.1.6
[Ref.: #116742]	catalase	+	1.11.1.6
[Ref.: #68382]	cystine arylamidase	-	3.4.11.3	* from API zym
[Ref.: #68369]	cytochrome oxidase	-	1.9.3.1	* from API 20NE
[Ref.: #68382]	esterase (C 4)	+		* from API zym
[Ref.: #68382]	esterase lipase (C 8)	+		* from API zym
[Ref.: #116742]	gamma-glutamyltransferase	+	2.3.2.2
[Ref.: #116742]	gelatinase	-
[Ref.: #68382]	leucine arylamidase	+	3.4.11.1	* from API zym
[Ref.: #68382]	lipase (C 14)	-		* from API zym
[Ref.: #68382]	N-acetyl-beta-glucosaminidase	-	3.2.1.52	* from API zym
[Ref.: #68382]	naphthol-AS-BI-phosphohydrolase	+		* from API zym
[Ref.: #116742]	oxidase	-
[Ref.: #68382]	trypsin	-	3.4.21.4	* from API zym
[Ref.: #116742]	urease	-	3.5.1.5
[Ref.: #68369]	urease	-	3.5.1.5	* from API 20NE
[Ref.: #68382]	valine arylamidase	-		* from API zym
	Only first 10 entries are displayed. Click here to see all.

API® 20NE:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Reduction of nitratesNO3	Indole productionTRP	Fermentation of D-glucoseGLU_ Ferm	Arginine dihydrolaseADH (Arg)	Urease/urea hydrolysisURE	Esculin hydrolysis/beta-GlucosidaseESC	Gelatinase/gelatin hydrolysisGEL	beta-GalactosidasePNPG	Assimilation of D-glucoseGLU_ Assim	Assimilation of L-arabinoseARA	Assimilation of D-mannoseMNE	Assimilation of D-mannitolMAN	Assimilation of N-acetyl-glucosamineNAG	Assimilation of maltoseMAL	Assimilation of gluconateGNT	Assimilation of capric acidCAP	Assimilation adipic acidADI	Assimilation of malic acidMLT	Assimilation of citric acidCIT	Assimilation of phenyl-acetic acidPAC	Cytochrome oxidaseOX
[Ref.: #9084]	25286	-	-	+	-	-	-	-	-	+/-	+	-	-	-	-	-	+	+	+	+	+	-
[Ref.: #9084]	24983	-	-	+	-	-	-	-	-	-	+	-	-	-	-	-	+	+	+	+	+	-
[Ref.: #9084]	24680	-	-	-	-	-	-	+	-	-	+	-	-	-	-	-	+	+	+	+	+	-
[Ref.: #9084]	24320	-	-	-	-	-	-	-	-	+	+	-	-	-	-	-	+	+	+	+	+	-
[Ref.: #9084]	24095	-	-	+	-	-	-	-	-	-	+	-	-	-	-	-	+	+	+	+	+	-
[Ref.: #9084]	24094	-	-	+	-	-	-	-	-	-	+	-	-	-	-	-	+	+	+	+	+	not determinedn.d.
[Ref.: #9084]	24093	-	-	+	-	-	-	-	-	+/-	+	-	-	-	-	-	+	+	+	+	+	not determinedn.d.
[Ref.: #9084]	24092	-	-	+	-	-	-	-	-	+/-	+	-	-	-	-	-	+	+	+	+	+	-

API® 50CH acid:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	ControlQ	Acid from glycerolGLY	Acid from erythritolERY	Acid from D-arabinoseDARA	Acid from L-arabinoseLARA	Acid from D-riboseRIB	Acid from D-xyloseDXYL	Acid from L-xyloseLXYL	Acid from D-adonitolADO	Acid from methyl beta-D-xylopyranosideMDX	Acid from D-galactoseGAL	Acid from D-glucoseGLU	Acid from D-fructoseFRU	Acid from D-mannoseMNE	Acid from L-sorboseSBE	Acid from L-rhamnoseRHA	Acid from dulcitolDUL	Acid from inositolINO	Acid from D-mannitolMAN	Acid from D-sorbitolSOR	Acid from methyl alpha-D-mannopyranosideMDM	Acid from methyl alpha-D-glucopyranosideMDG	Acid from N-acetyl-glucosamineNAG	Acid from amygdalinAMY	Acid from arbutinARB	Acid from esculinESC	Acid from salicinSAL	Acid from cellobioseCEL	Acid from maltoseMAL	Acid from lactoseLAC	Acid from melibioseMEL	Acid from sucroseSAC	Acid from trehaloseTRE	Acid from inulinINU	Acid from melezitoseMLZ	Acid from raffinoseRAF	Acid from starchAMD	Acid from glycogenGLYG	Acid from xylitolXLT	Acid from gentiobioseGEN	Acid from turanoseTUR	Acid from D-lyxoseLYX	Acid from D-tagatoseTAG	Acid from D-fucoseDFUC	Acid from L-fucoseLFUC	Acid from D-arabitolDARL	Acid from L-arabitolLARL	Acid from gluconateGNT	Acid from 2-Ketogluconate2KG	Acid from 5-Ketogluconate5KG
[Ref.: #116742]	12087	not determinedn.d.	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

API® Biotype100:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	ControlQ	D-glucose as carbon sourceGLU	D-fructose as carbon sourceFRU	D-galactose as carbon sourceGAL	D-trehalose as carbon sourceTRE	D-mannose as carbon sourceMNE	L-sorbose as carbon sourceSBE	D-melibiose as carbon sourceMEL	sucrose as carbon sourceSAC	D-raffinose as carbon sourceRAF	maltotriose as carbon sourceMTE	maltose as carbon sourceMAL	lactose as carbon sourceLAC	lactulose as carbon sourceLTE	1-O-methyl-beta-galactopyranoside as carbon sourceMbGa	1-O-methyl-alpha-galactopyranoside as carbon sourceMaGa	D-cellobiose as carbon sourceCEL	gentiobiose as carbon sourceGEN	1-O-methyl-beta-D-glucopyranoside as carbon sourceMbGu	esculin as carbon sourceESC	D-ribose as carbon sourceRIB	L-arabinose as carbon sourceARA	D-xylose as carbon sourceXYL	palatinose as carbon sourcePLE	L-rhamnose as carbon sourceRHA	L-fucose as carbon sourceFUC	D-melezitose as carbon sourceMLZ	D-arabitol as carbon sourceDARL	L-arabitol as carbon sourceLARL	xylitol as carbon sourceXLT	dulcitol as carbon sourceDUL	D-tagatose as carbon sourceTAG	glycerol as carbon sourceGLY	myo-inositol as carbon sourceINO	D-mannitol as carbon sourceMAN	maltitol as carbon sourceMTL	D-turanose as carbon sourceTUR	D-sorbitol as carbon sourceSOR	adonitol as carbon sourceADO	hydroxyquinoline-beta-glucuronide as carbon sourceHBG	D-lyxose as carbon sourceLYX	i-erythritol as carbon sourceERY	1-O-methyl-alpha-D-glucoside as carbon sourceMDG	3-O-methyl-D-glucose as carbon source3MDG	D-saccharate as carbon sourceSAT	mucate as carbon sourceMUC	L-tartrate as carbon sourceLTAT	D-tartrate as carbon sourceDTAT	meso-tartrate as carbon sourceMTAT	D-malate as carbon sourceDMLT	L-malate as carbon sourceLMLT	cis-aconitate as carbon sourceCATE	trans-aconitate as carbon sourceTATE	tricarballylate as carbon sourceTTE	citrate as carbon sourceCIT	D-glucuronate as carbon sourceGRT	D-galacturonate as carbon sourceGAT	2-ketogluconate as carbon source2KG	5-ketogluconate as carbon source5KG	tryptophan as carbon sourceTRY	N-acetyl-D-glucosamine as carbon sourceNAG	D-gluconate as carbon sourceGNT	phenylacetate as carbon sourcePAC	protocatechuate as carbon sourcePAT	4-hydroxybenzoate as carbon sourcepOBE	quinate as carbon sourceQAT	gentisate as carbon sourceGTE	3-hydroxybenzoate as carbon sourcemOBE	benzoate as carbon sourceBAT	3-phenylpropionate as carbon sourcePPAT	m-coumarate as carbon sourceCMT	trigonelline as carbon sourceTGE	betaine as carbon sourceBET	putrescine as carbon sourcePCE	4-aminobutyrate as carbon sourceABT	histamine as carbon sourceHIN	DL-lactate as carbon sourceLAT	caprate as carbon sourceCAP	caprylate as carbon sourceCYT	L-histidine as carbon sourceHIS	succinate as carbon sourceSUC	fumarate as carbon sourceFUM	glutarate as carbon sourceGRE	DL-glycerate as carbon sourceGYT	5-aminovalerate as carbon sourceAVT	ethanolamine as carbon sourceETN	tryptamine as carbon sourceTTN	D-glucosamine as carbon sourceGLN	itaconate as carbon sourceITA	3-hydroxybutyrate as carbon source3OBU	L-aspartate as carbon sourceAPT	L-glutamate as carbon sourceGTT	L-proline as carbon sourcePRO	D-alanine as carbon sourceDALA	L-alanine as carbon sourceLALA	L-serine as carbon sourceSER	malonate as carbon sourceMNT	propionate as carbon sourcePROP	L-tyrosine as carbon sourceTYR	2-ketoglutarate as carbon source2KT
[Ref.: #116742]	3287	not determinedn.d.	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	+	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	+	-	-	-	+	+	+	+	+	+	-	-	-	-	+	-	-	+	+	+	+	-	-	+	-	-	+	-	+	+	-	+	+	+	+	+	+	+	-	-	-	-	-	-	+	+	+	+	+	+	-	+	+	+	-

API® zym:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Control	2-naphthyl phosphateAlkaline phosphatase	2-naphthyl butyrateEsterase (C 4)	2-naphtyl caprylateEsterase Lipase (C 8)	2-naphthyl myristateLipase (C 14)	L-leucyl-2-naphthylamideLeucine arylamidase	L-valyl-2-naphthylamideValine arylamidase	L-cystyl-2-naphthylamideCystine arylamidase	N-benzoyl-DL-arginine-2-naphthylamideTrypsin	N-glutaryl-phenylalanine-2-naphthylamidealpha- Chymotrypsin	2-naphthyl phosphateAcid phosphatase	Naphthol-AS-BI-phosphateNaphthol-AS-BI-phosphohydrolase	6-Br-2-naphthyl-alphaD-galactpyranosidealpha- Galactosidase	2-naphthyl-betaD-galactpyranosidebeta- Galactosidase	Naphthol-AS-BI-betaD-glucuronidebeta- Glucuronidase	2-naphthyl-alphaD-glucopyranosidealpha- Glucosidase	6-Br-2-naphthyl-betaD-glucopyranosidebeta- Glucosidase	1-naphthyl-N-acetyl-betaD-glucosaminideN-acetyl-beta- glucosaminidase	6-Br-2-naphthyl-alphaD-mannopyranosidealpha- Mannosidase	2-naphthyl-alphaL-fucopyranosidealpha- Fucosidase
[Ref.: #116742]	13199	-	+	+	+	-	+	-	-	-	-	+	+	-	-	-	-	-	-	-	-

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #9084]	Sample type/isolated from	urine

[Ref.: #67770]	Sample type/isolated from	Urine

[Ref.: #116742]	Sample type/isolated from	Urine
* marker position based on {}

Isolation sources categories

#Host Body Product

#Fluids

#Urine

What are isolation sources categories?

[Ref.: #69479]

Global distribution of 16S sequence Z93435 (>99% sequence identity) for Acinetobacter baumannii from Microbeatlas

Aquatic Samples	4013
Soil Samples	605
Animal Samples	5073
Plant Samples	534
Total Samples	10225

Information on possible application of the strain and its possible interaction with e.g. potential hosts Safety information

[Ref.: #9084]	Biosafety level	2	Risk group (German classification) According to TRBA 466
[Ref.: #116742]	Biosafety level	1	Risk group (French classification)

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

16S Sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Sequence length (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #9084]	A.baumannii 16S rRNA gene (DSM30007)	X81660	1459	ENA	470 tax ID
[Ref.: #67770]	Acinetobacter baumannii gene for 16S rRNA, partial sequence, strain: JCM 6841	AB594765	1459	ENA	470 tax ID
[Ref.: #9084]	Acinetobacter baumannii partial 16S rRNA gene, type strain DSM 30007T	HE978267	1515	ENA	470 tax ID
[Ref.: #20218]	Acinetobacter baumannii genomic DNA containing 16S-23S IGS, strain ATCC 19606, clone 01	HE651629	608	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumannii genomic DNA containing 16S-23S IGS, strain ATCC 19606, clone 03	HE651630	608	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumannii genomic DNA containing 16S-23S IGS, strain ATCC 19606, clone 04	HE651631	608	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumannii genomic DNA containing 16S-23S IGS, strain ATCC 19606, clone 05	HE651632	608	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumannii genomic DNA containing 16S-23S IGS, strain ATCC 19606, clone 06	HE651633	608	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumannii genomic DNA containing 16S-23S IGS, strain ATCC 19606, clone 09	HE651634	608	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumannii genomic DNA containing 16S-23S IGS, strain ATCC 19606, clone 10	HE651635	608	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumannii genomic DNA containing 16S-23S IGS, strain ATCC 19606, clone 11	HE651636	608	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumannii genomic DNA containing 16S-23S IGS, strain ATCC 19606, clone 13	HE651637	608	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumannii genomic DNA containing 16S-23S IGS, strain ATCC 19606, clone 18	HE651638	608	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumannii genomic DNA containing 16S-23S IGS, strain ATCC 19606, clone 22	HE651639	608	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumannii 16S-23S ribosomal RNA intergenic spacer, including Ile-tRNA and Ala-tRNA genes	U60279	621	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumannii strain CIP 70.34 16S ribosomal RNA gene, partial sequence	FJ867354	1528	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumannii 16S rRNA gene, partial	AJ247197	452	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumanni 16S rRNA gene (strain ATCC 19606T)	Z93435	1416	ENA	470 tax ID	*
[Ref.: #20218]	Acinetobacter baumannii 16S rRNA gene, strain ATCC 19606	HE651907	1529	ENA	470 tax ID	*

Genome sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Assembly level	Sequence database	Associated NCBI tax ID
[Ref.: #67770]	Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841	GCA_000162295	scaffold	GenBank	575584 tax ID
[Ref.: #66792]	Acinetobacter baumannii 81	GCA_018123985	contig	GenBank	470 tax ID	*
[Ref.: #66792]	Acinetobacter baumannii ATCC 19606	GCA_009759685	complete	GenBank	470 tax ID	*
[Ref.: #66792]	Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841	GCA_019331655	complete	GenBank	575584 tax ID	*
[Ref.: #66792]	Acinetobacter baumannii NCTC12156	GCA_900444725	contig	GenBank	470 tax ID	*
[Ref.: #66792]	Acinetobacter baumannii ATCC 19606	GCA_014116795	scaffold	GenBank	470 tax ID	*

Data predicted using genome information as a basis Genome-based predictions

	Trait	Prediction	Confidence in %	In training data
	Predictions from GenomeNet Sporulation v. 1 based on: Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841 PATRIC: 575584.58
[Ref.: #69481]	spore-forming	no	100	no

	Trait	Prediction	Confidence in %	In training data
	Predictions from Diaspora project based on: Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841 ATCC 19606 NCBI: GCA_019331655.1
[Ref.: #69480]	flagellated	no	92.922	no
[Ref.: #69480]	gram-positive	no	96.962	no
[Ref.: #69480]	anaerobic	no	98.373	no
[Ref.: #69480]	aerobic	yes	93.997	no
[Ref.: #69480]	halophile	no	90.999	no
[Ref.: #69480]	spore-forming	no	96.319	no
[Ref.: #69480]	motile	no	91.55	no
[Ref.: #69480]	thermophile	no	99.868	no
[Ref.: #69480]	glucose-util	no	62.007	no
[Ref.: #69480]	glucose-ferment	no	82.112	no

Availability in culture collections External links

[Ref.: #9084]

Culture collection no.

DSM 30007, ATCC 19606, CIP 70.34, DSM 6974, JCM 6841, CCUG 19096, CGMCC 1.6769, IAM 12088, KCTC 2508, LMG 1041, LMG 10545, NBRC 109757, NCIMB 12457, NCTC 12156

[Ref.: #77520]

SI-ID 92085

Literature:

Only first 10 entries are displayed. Click here to see all.

	Title	Authors	Journal	DOI	Year
Phylogeny	Genome diversity of domesticated Acinetobacter baumannii ATCC 19606(T) strains.	Artuso I, Lucidi M, Visaggio D, Capecchi G, Lugli GA, Ventura M, Visca P	Microb Genom	10.1099/mgen.0.000749	2022	*
Pathogenicity	Antimicrobial and anti-biofilm potencies of dermcidin-derived peptide DCD-1L against Acinetobacter baumannii: an in vivo wound healing model.	Farshadzadeh Z, Pourhajibagher M, Taheri B, Ekrami A, Modarressi MH, Azimzadeh M, Bahador A	BMC Microbiol	10.1186/s12866-022-02439-8	2022	*
Pathogenicity	Integrating transcriptomics and metabolomics analysis on kojic acid combating Acinetobacter baumannii biofilm and its potential roles.	Li H, Du X, Chen C, Qi J, Wang Y	Microbiol Res	10.1016/j.micres.2021.126911	2021	*
Metabolism	CsrA Coordinates Compatible Solute Synthesis in Acinetobacter baumannii and Facilitates Growth in Human Urine.	Hubloher JJ, Schabacker K, Muller V, Averhoff B	Microbiol Spectr	10.1128/Spectrum.01296-21	2021	*
Proteome	Strategies for Rapid Identification of Acinetobacter baumannii Membrane Proteins and Polymyxin B's Effects.	Lu Y, Hu X, Nie T, Yang X, Li C, You X	Front Cell Infect Microbiol	10.3389/fcimb.2021.734578	2021	*
Metabolism	Role of Iron-Containing Alcohol Dehydrogenases in Acinetobacter baumannii ATCC 19606 Stress Resistance and Virulence.	Lin GH, Hsieh MC, Shu HY	Int J Mol Sci	10.3390/ijms22189921	2021	*
Pathogenicity	Synergism versus Additivity: Defining the Interactions between Common Disinfectants.	Noel DJ, Keevil CW, Wilks SA	mBio	10.1128/mBio.02281-21	2021	*
Phylogeny	Description of Lujinxingia vulgaris sp. nov., isolated from coastal sediment via prey-traps.	Wang S, Mu DS, Li GY, Du ZJ	Antonie Van Leeuwenhoek	10.1007/s10482-021-01640-5	2021	*
Metabolism	Modern Acinetobacter baumannii clinical isolates replicate inside spacious vacuoles and egress from macrophages.	Sycz G, Di Venanzio G, Distel JS, Sartorio MG, Le NH, Scott NE, Beatty WL, Feldman MF	PLoS Pathog	10.1371/journal.ppat.1009802	2021	*
Pathogenicity	Novel Phenyl-Based Bis-quaternary Ammonium Compounds as Broad-Spectrum Biocides.	Frolov NA, Fedoseeva KA, Hansford KA, Vereshchagin AN	ChemMedChem	10.1002/cmdc.202100284	2021	*
Pathogenicity	K(+) and its role in virulence of Acinetobacter baumannii.	Konig P, Averhoff B, Muller V	Int J Med Microbiol	10.1016/j.ijmm.2021.151516	2021	*
Metabolism	Comparison of the Acinetobacter baumannii Reference Strains ATCC 17978 and ATCC 19606 in Antimicrobial Resistance Mediated by the AdeABC Efflux Pump.	Lucassen K, Gerson S, Xanthopoulou K, Wille J, Wille T, Seifert H, Higgins PG	Antimicrob Agents Chemother	10.1128/AAC.00570-21	2021	*
Genetics	Two Acinetobacter baumannii Isolates Obtained From a Fatal Necrotizing Fasciitis Infection Display Distinct Genomic and Phenotypic Characteristics in Comparison to Type Strains.	Grier JT, Arivett BA, Ramirez MS, Chosed RJ, Bigner JA, Ohneck EJ, Metz ML, Wood CR, Arce S, Tartaro A, Relich RF, Actis LA, Fiester SE	Front Cell Infect Microbiol	10.3389/fcimb.2021.635673	2021	*
Pathogenicity	PHMB-loaded PDMS and its antimicrobial properties for biomedical applications.	Montemezzo M, Ferrari MD, Kerstner E, Santos VD, Victorazzi Lain V, Wollheim C, Frozza CODS, Roesch-Ely M, Baldo G, Brandalise RN	J Biomater Appl	10.1177/08853282211011921	2021	*
Pathogenicity	Acinetobacter baumannii LOS Regulate the Expression of Inflammatory Cytokine Genes and Proteins in Human Mast Cells.	Kikuchi-Ueda T, Ubagai T, Kamoshida G, Nakano R, Nakano A, Ono Y	Pathogens	10.3390/pathogens10030290	2021	*
Pathogenicity	Investigation of antibiofilm activity, antibacterial activity, and mechanistic studies of an amphiphilic peptide against Acinetobacter baumannii.	Zeng P, Yi L, Xu J, Gao W, Xu C, Chen S, Chan KF, Wong KY	Biochim Biophys Acta Biomembr	10.1016/j.bbamem.2021.183600	2021	*
Pathogenicity	AB569, a non-toxic combination of acidified nitrite and EDTA, is effective at killing the notorious Iraq/Afghanistan combat wound pathogens, multi-drug resistant Acinetobacter baumannii and Acinetobacter spp.	Bogue AL, Panmanee W, McDaniel CT, Mortensen JE, Kamau E, Actis LA, Johannigman JA, Schurr MJ, Satish L, Kotagiri N, Hassett DJ	PLoS One	10.1371/journal.pone.0247513	2021	*
Pathogenicity	Time-kill and post-antibiotic effect of colistin at different static concentrations in in vitro Acinetobacter baumannii.	Rasidin RSM, Suhaili Z, Mohamed AFS, Hod R, Neela V, Amin-Nordin S	Trop Biomed		2020	*
Phylogeny	Acinetobacter stercoris sp. nov. isolated from output source of a mesophilic german biogas plant with anaerobic operating conditions.	Pulami D, Schauss T, Eisenberg T, Blom J, Schwengers O, Bender JK, Wilharm G, Kampfer P, Glaeser SP	Antonie Van Leeuwenhoek	10.1007/s10482-021-01517-7	2021	*
Pathogenicity	The Low-Alkalinity Polymyxin Derivative, AL-6, Shows High Activity Against Multidrug-Resistant Acinetobacter baumannii Clinical Isolates In Vitro and A. baumannii ATCC 19606 In Vivo: Preliminary Analysis of the Antibacterial Mechanism.	Chen DJ, Cui AL, Chen JR, Yang P, Jin J, Shao L, Li ZR	Microb Drug Resist	10.1089/mdr.2019.0474	2021	*
Pathogenicity	A small molecule interacts with pMAC-derived hydroperoxide reductase and enhances the activity of aminoglycosides.	Hui Z, Liu S, Cui R, Zhou B, Hu C, Zhang M, Deng Q, Cheng S, Luo Y, Chen H, Wu J, Lu Y, Liu X, Dai L, Huang W	J Antibiot (Tokyo)	10.1038/s41429-020-00401-2	2021	*
Metabolism	Analysis of Immune Responses in Acinetobacter baumannii-Infected Klotho Knockout Mice: A Mouse Model of Acinetobacter baumannii Infection in Aged Hosts.	Sato Y, Tansho-Nagakawa S, Ubagai T, Ono Y	Front Immunol	10.3389/fimmu.2020.601614	2020	*
Genetics	Analysis of Complete Genome Sequence of Acinetobacter baumannii Strain ATCC 19606 Reveals Novel Mobile Genetic Elements and Novel Prophage.	Hamidian M, Blasco L, Tillman LN, To J, Tomas M, Myers GSA	Microorganisms	10.3390/microorganisms8121851	2020	*
Metabolism	In vivo synthesis of monolysocardiolipin and cardiolipin by Acinetobacter baumannii phospholipase D and effect on cationic antimicrobial peptide resistance.	Pfefferle K, Lopalco P, Breisch J, Siemund A, Corcelli A, Averhoff B	Environ Microbiol	10.1111/1462-2920.15231	2020	*
Phylogeny	Characterization of carbapenem-resistant hypervirulent Acinetobacter baumannii strains isolated from hospitalized patients in the mid-south region of China.	Li J, Yu T, Luo Y, Peng JY, Li YJ, Tao XY, Hu YM, Wang HC, Zou MX	BMC Microbiol	10.1186/s12866-020-01957-7	2020	*
Metabolism	Trehalose-6-phosphate-mediated phenotypic change in Acinetobacter baumannii.	Hubloher JJ, Zeidler S, Lamosa P, Santos H, Averhoff B, Muller V	Environ Microbiol	10.1111/1462-2920.15148	2020	*
Pathogenicity	Pan-transcriptomic analysis identified common differentially expressed genes of Acinetobacter baumannii in response to polymyxin treatments.	Li M, Aye SM, Ahmed MU, Han ML, Li C, Song J, Boyce JD, Powell DR, Azad MAK, Velkov T, Zhu Y, Li J	Mol Omics	10.1039/d0mo00015a	2020	*
Pathogenicity	Prevention of nosocomial Acinetobacter baumannii infections with a conserved immunogenic fimbrial protein.	Mahmoudi Z, Rasooli I, Jahangiri A, Darvish Alipour Astaneh S	APMIS	10.1111/apm.13061	2020	*
Genetics	Complete Genome Sequence of Acinetobacter baumannii ATCC 19606(T), a Model Strain of Pathogenic Bacteria Causing Nosocomial Infection.	Tsubouchi T, Suzuki M, Niki M, Oinuma KI, Niki M, Kakeya H, Kaneko Y	Microbiol Resour Announc	10.1128/MRA.00289-20	2020	*
Phylogeny	Decreased carO gene expression and OXA-type carbapenemases among extensively drug-resistant Acinetobacter baumannii strains isolated from burn patients in Tehran, Iran.	Abbasi E, Goudarzi H, Hashemi A, Chirani AS, Ardebili A, Goudarzi M, Sharahi JY, Davoudabadi S, Talebi G, Bostanghadiri N	Acta Microbiol Immunol Hung	10.1556/030.2020.01138	2020	*
Pathogenicity	Healthcare-associated carbapenem-resistant OXA-72-producing Acinetobacter baumannii of the clonal complex CC79 colonizing migratory and captive aquatic birds in a Brazilian Zoo.	Narciso AC, Martins WMBS, Almeida LGP, Cayo R, Santos SV, Ramos PL, Lincopan N, Vasconcelos ATR, Gales AC	Sci Total Environ	10.1016/j.scitotenv.2020.138232	2020	*
Pathogenicity	New Mutations Involved in Colistin Resistance in Acinetobacter baumannii.	Sun B, Liu H, Jiang Y, Shao L, Yang S, Chen D	mSphere	10.1128/mSphere.00895-19	2020	*
Pathogenicity	Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China.	Chen L, Lin J, Lu H, Zhang X, Wang C, Liu H, Zhang X, Li J, Cao J, Zhou T	J Antibiot (Tokyo)	10.1038/s41429-020-0289-2	2020	*
Genetics	Complete genome sequence and genome-scale metabolic modelling of Acinetobacter baumannii type strain ATCC 19606.	Zhu Y, Lu J, Zhao J, Zhang X, Yu HH, Velkov T, Li J	Int J Med Microbiol	10.1016/j.ijmm.2020.151412	2020	*
Metabolism	Unusual deprivation of compatible solutes in Acinetobacter baumannii.	Zeidler S, Muller V	Environ Microbiol	10.1111/1462-2920.14951	2020	*
Transcriptome	Integrative analysis of outer membrane vesicles proteomics and whole-cell transcriptome analysis of eravacycline induced Acinetobacter baumannii strains.	Kesavan D, Vasudevan A, Wu L, Chen J, Su Z, Wang S, Xu H	BMC Microbiol	10.1186/s12866-020-1722-1	2020	*
Pathogenicity	The Acinetobacter trimeric autotransporter adhesin Ata controls key virulence traits of Acinetobacter baumannii.	Weidensdorfer M, Ishikawa M, Hori K, Linke D, Djahanschiri B, Iruegas R, Ebersberger I, Riedel-Christ S, Enders G, Leukert L, Kraiczy P, Rothweiler F, Cinatl J, Berger J, Hipp K, Kempf VAJ, Gottig S	Virulence	10.1080/21505594.2018.1558693	2019	*
Pathogenicity	Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii.	Gerson S, Lucassen K, Wille J, Nodari CS, Stefanik D, Nowak J, Wille T, Betts JW, Roca I, Vila J, Cisneros JM, Seifert H, Higgins PG	Int J Antimicrob Agents	10.1016/j.ijantimicag.2019.105862	2019	*
Pathogenicity	Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages.	Sato Y, Unno Y, Miyazaki C, Ubagai T, Ono Y	Sci Rep	10.1038/s41598-019-53846-3	2019	*
Pathogenicity	New Shuttle Vectors for Real-Time Gene Expression Analysis in Multidrug-Resistant Acinetobacter Species: In Vitro and In Vivo Responses to Environmental Stressors.	Lucidi M, Visaggio D, Prencipe E, Imperi F, Rampioni G, Cincotti G, Leoni L, Visca P	Appl Environ Microbiol	10.1128/AEM.01334-19	2019	*
Pathogenicity	Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant Acinetobacter baumannii.	Mujawar S, Mishra R, Pawar S, Gatherer D, Lahiri C	Front Cell Infect Microbiol	10.3389/fcimb.2019.00203	2019	*
Pathogenicity	Analysis of Acinetobacter baumannii survival in liquid media and on solid matrices as well as effect of disinfectants.	Bravo Z, Orruno M, Navascues T, Ogayar E, Ramos-Vivas J, Kaberdin VR, Arana I	J Hosp Infect	10.1016/j.jhin.2019.04.009	2019	*
Metabolism	The chloramphenicol/H+ antiporter CraA of Acinetobacter baumannii AYE reveals a broad substrate specificity.	Foong WE, Tam HK, Crames JJ, Averhoff B, Pos KM	J Antimicrob Chemother	10.1093/jac/dkz024	2019	*
Pathogenicity	Isothiazolopyridine Mannich bases and their antibacterial effect.	Swiatek P, Strzelecka M	Adv Clin Exp Med	10.17219/acem/99310	2019	*
Pathogenicity	Miltefosine Reduces the Cytolytic Activity and Virulence of Acinetobacter baumannii.	Fiester SE, Arivett BA, Beckett AC, Wagner BR, Ohneck EJ, Schmidt RE, Grier JT, Actis LA	Antimicrob Agents Chemother	10.1128/AAC.01409-18	2018	*
Metabolism	Identification and characterization of a carnitine transporter in Acinetobacter baumannii.	Breisch J, Waclawska I, Averhoff B	Microbiologyopen	10.1002/mbo3.752	2018	*
Metabolism	The role of compatible solutes in desiccation resistance of Acinetobacter baumannii.	Zeidler S, Muller V	Microbiologyopen	10.1002/mbo3.740	2018	*
Metabolism	Biological roles of indole-3-acetic acid in Acinetobacter baumannii.	Lin HR, Shu HY, Lin GH	Microbiol Res	10.1016/j.micres.2018.08.004	2018	*
Pathogenicity	Antimicrobial Activity of Selected Antimicrobial Peptides Against Planktonic Culture and Biofilm of Acinetobacter baumannii.	Jaskiewicz M, Neubauer D, Kazor K, Bartoszewska S, Kamysz W	Probiotics Antimicrob Proteins	10.1007/s12602-018-9444-5	2019	*
Pathogenicity	Characterization and Transcriptome Analysis of Acinetobacter baumannii Persister Cells.	Alkasir R, Ma Y, Liu F, Li J, Lv N, Xue Y, Hu Y, Zhu B	Microb Drug Resist	10.1089/mdr.2017.0341	2018	*
Metabolism	Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.	Carretero-Ledesma M, Garcia-Quintanilla M, Martin-Pena R, Pulido MR, Pachon J, McConnell MJ	Virulence	10.1080/21505594.2018.1460187	2018	*
Metabolism	Salt induction and activation of MtlD, the key enzyme in the synthesis of the compatible solute mannitol in Acinetobacter baumannii.	Zeidler S, Hubloher J, Konig P, Ngu ND, Scholz A, Averhoff B, Muller V	Microbiologyopen	10.1002/mbo3.614	2018	*
Pathogenicity	Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation.	Sato Y, Unno Y, Ubagai T, Ono Y	PLoS One	10.1371/journal.pone.0194556	2018	*
Phylogeny	Streptosporangium minutum sp. nov., isolated from garden soil exposed to microwave radiation.	Le Roes-Hill M, Durrell K, Prins A, Meyers PR	J Antibiot (Tokyo)	10.1038/s41429-018-0036-0	2018	*
Metabolism	A pathway-directed positive growth restoration assay to facilitate the discovery of lipid A and fatty acid biosynthesis inhibitors in Acinetobacter baumannii.	Richie DL, Wang L, Chan H, De Pascale G, Six DA, Wei JR, Dean CR	PLoS One	10.1371/journal.pone.0193851	2018	*
Pathogenicity	The role of the type VI secretion system vgrG gene in the virulence and antimicrobial resistance of Acinetobacter baumannii ATCC 19606.	Wang J, Zhou Z, He F, Ruan Z, Jiang Y, Hua X, Yu Y	PLoS One	10.1371/journal.pone.0192288	2018	*
Transcriptome	Mucin acts as a nutrient source and a signal for the differential expression of genes coding for cellular processes and virulence factors in Acinetobacter baumannii.	Ohneck EJ, Arivett BA, Fiester SE, Wood CR, Metz ML, Simeone GM, Actis LA	PLoS One	10.1371/journal.pone.0190599	2018	*
Pathogenicity	Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii.	Ackerman DL, Craft KM, Doster RS, Weitkamp JH, Aronoff DM, Gaddy JA, Townsend SD	ACS Infect Dis	10.1021/acsinfecdis.7b00183	2017	*
Pathogenicity	In vitro antimicrobial effects of a novel Pentaherbs concoction for atopic dermatitis.	Hon KL, Ip M, Wong CK, Chan BCL, Leung PC, Leung TF	J Dermatolog Treat	10.1080/09546634.2017.1395804	2017	*
Transcriptome	Characterization of the DNA mismatch repair proteins MutS and MutL in a hypermutator Acinetobacter baumannii.	Deihim B, Hassanzadeh M, Shafiei-Jandaghi NZ, Amanlou M, Douraghi M	Microb Pathog	10.1016/j.micpath.2017.10.001	2017	*
Metabolism	The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.	Wang-Lin SX, Olson R, Beanan JM, MacDonald U, Balthasar JP, Russo TA	Infect Immun	10.1128/IAI.00591-17	2017	*
Pathogenicity	Antibacterial activity of exogenous glutathione and its synergism on antibiotics sensitize carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.	Alharbe R, Almansour A, Kwon DH	Int J Med Microbiol	10.1016/j.ijmm.2017.07.009	2017	*
Enzymology	Phytochemical Studies on Two Australian Anigozanthos Plant Species.	Hendra R, Keller PA	J Nat Prod	10.1021/acs.jnatprod.7b00063	2017	*
Pathogenicity	Subinhibitory Concentrations of Trimethoprim and Sulfamethoxazole Prevent Biofilm Formation by Acinetobacter baumannii through Inhibition of Csu Pilus Expression.	Moon KH, Weber BS, Feldman MF	Antimicrob Agents Chemother	10.1128/AAC.00778-17	2017	*
Phylogeny	Identification of Acinetobacter baumannii of Human and Animal Origins by a Gene-Specific PCR.	Hamouda A	Curr Microbiol	10.1007/s00284-017-1283-1	2017	*
Pathogenicity	Constraint-based modeling identifies new putative targets to fight colistin-resistant A. baumannii infections.	Presta L, Bosi E, Mansouri L, Dijkshoorn L, Fani R, Fondi M	Sci Rep	10.1038/s41598-017-03416-2	2017	*
Pathogenicity	Identification of unique cardiolipin and monolysocardiolipin species in Acinetobacter baumannii.	Lopalco P, Stahl J, Annese C, Averhoff B, Corcelli A	Sci Rep	10.1038/s41598-017-03214-w	2017	*
Enzymology	Acinetobacter baumannii transfers the blaNDM-1 gene via outer membrane vesicles.	Chatterjee S, Mondal A, Mitra S, Basu S	J Antimicrob Chemother	10.1093/jac/dkx131	2017	*
Enzymology	Filamentous hemagglutinin adhesin FhaB limits A.baumannii biofilm formation.	Darwish Alipour Astaneh S, Rasooli I, Mousavi Gargari SL	Front Biosci (Elite Ed)	10.2741/e801	2017	*
Pathogenicity	Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol.	Wei WJ, Yang HF	Int J Antimicrob Agents	10.1016/j.ijantimicag.2016.11.031	2017	*
Metabolism	Virulence characteristics of Acinetobacter baumannii clinical isolates vary with the expression levels of omps.	Sato Y, Unno Y, Kawakami S, Ubagai T, Ono Y	J Med Microbiol	10.1099/jmm.0.000394	2017	*
Enzymology	Iron-Regulated Phospholipase C Activity Contributes to the Cytolytic Activity and Virulence of Acinetobacter baumannii.	Fiester SE, Arivett BA, Schmidt RE, Beckett AC, Ticak T, Carrier MV, Ghosh R, Ohneck EJ, Metz ML, Sellin Jeffries MK, Actis LA	PLoS One	10.1371/journal.pone.0167068	2016	*
Pathogenicity	A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii.	Boll JM, Crofts AA, Peters K, Cattoir V, Vollmer W, Davies BW, Trent MS	Proc Natl Acad Sci U S A	10.1073/pnas.1611594113	2016	*
Pathogenicity	Association of biofilm production with colonization among clinical isolates of Acinetobacter baumannii.	Ryu SY, Baek WK, Kim HA	Korean J Intern Med	10.3904/kjim.2015.287	2016	*
Pathogenicity	High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii.	Lenhard JR, Bulitta JB, Connell TD, King-Lyons N, Landersdorfer CB, Cheah SE, Thamlikitkul V, Shin BS, Rao G, Holden PN, Walsh TJ, Forrest A, Nation RL, Li J, Tsuji BT	J Antimicrob Chemother	10.1093/jac/dkw355	2016	*
Genetics	Genome Sequence of Jumbo Phage vB_AbaM_ME3 of Acinetobacter baumanni.	Buttimer C, O'Sullivan L, Elbreki M, Neve H, McAuliffe O, Ross RP, Hill C, O'Mahony J, Coffey A	Genome Announc	10.1128/genomeA.00431-16	2016	*
Metabolism	Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606.	Richie DL, Takeoka KT, Bojkovic J, Metzger LE 4th, Rath CM, Sawyer WS, Wei JR, Dean CR	PLoS One	10.1371/journal.pone.0160918	2016	*
Pathogenicity	Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies.	Rao GG, Ly NS, Bulitta JB, Soon RL, San Roman MD, Holden PN, Landersdorfer CB, Nation RL, Li J, Forrest A, Tsuji BT	J Antimicrob Chemother	10.1093/jac/dkw293	2016	*
Pathogenicity	5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii.	Tseng SP, Hung WC, Huang CY, Lin YS, Chan MY, Lu PL, Lin L, Sheu JH	Mar Drugs	10.3390/md14080143	2016	*
Pathogenicity	Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.	Rao GG, Ly NS, Diep J, Forrest A, Bulitta JB, Holden PN, Nation RL, Li J, Tsuji BT	Int J Antimicrob Agents	10.1016/j.ijantimicag.2016.06.006	2016	*
Pathogenicity	Modulation of virulence in Acinetobacter baumannii cells surviving photodynamic treatment with toluidine blue.	Pourhajibagher M, Boluki E, Chiniforush N, Pourakbari B, Farshadzadeh Z, Ghorbanzadeh R, Aziemzadeh M, Bahador A	Photodiagnosis Photodyn Ther	10.1016/j.pdpdt.2016.07.007	2016	*
Pathogenicity	Aptamer-nanobody based ELASA for specific detection of Acinetobacter baumannii isolates.	Rasoulinejad S, Gargari SLM	J Biotechnol	10.1016/j.jbiotec.2016.05.024	2016	*
Pathogenicity	Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens.	Cheah SE, Johnson MD, Zhu Y, Tsuji BT, Forrest A, Bulitta JB, Boyce JD, Nation RL, Li J	Sci Rep	10.1038/srep26233	2016	*
Pathogenicity	Impaired growth under iron-limiting conditions associated with the acquisition of colistin resistance in Acinetobacter baumannii.	Lopez-Rojas R, Garcia-Quintanilla M, Labrador-Herrera G, Pachon J, McConnell MJ	Int J Antimicrob Agents	10.1016/j.ijantimicag.2016.03.010	2016	*
Pathogenicity	Relationship between Antibiotic Resistance, Biofilm Formation, and Biofilm-Specific Resistance in Acinetobacter baumannii.	Qi L, Li H, Zhang C, Liang B, Li J, Wang L, Du X, Liu X, Qiu S, Song H	Front Microbiol	10.3389/fmicb.2016.00483	2016	*
Metabolism	Isolation, identification and diesel-oil biodegradation capacities of indigenous hydrocarbon-degrading strains of Cellulosimicrobium cellulans and Acinetobacter baumannii from tarball at Terengganu beach, Malaysia.	Nkem BM, Halimoon N, Yusoff FM, Johari WLW, Zakaria MP, Medipally SR, Kannan N	Mar Pollut Bull	10.1016/j.marpolbul.2016.03.060	2016	*
Enzymology	Effects of Saline, an Ambient Acidic Environment, and Sodium Salicylate on OXA-Mediated Carbapenem Resistance in Acinetobacter baumannii.	Zander E, Seifert H, Higgins PG	Antimicrob Agents Chemother	10.1128/AAC.03010-15	2016	*
Metabolism	Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii.	Maifiah MH, Cheah SE, Johnson MD, Han ML, Boyce JD, Thamlikitkul V, Forrest A, Kaye KS, Hertzog P, Purcell AW, Song J, Velkov T, Creek DJ, Li J	Sci Rep	10.1038/srep22287	2016	*
Enzymology	Screening of Herbal-Based Bioactive Extract Against Carbapenem-Resistant Strain of Acinetobacter baumannii.	Tiwari M, Roy R, Tiwari V	Microb Drug Resist	10.1089/mdr.2015.0270	2016	*
Pathogenicity	The long-term survival of Acinetobacter baumannii ATCC 19606(T) under nutrient-deprived conditions does not require the entry into the viable but non-culturable state.	Bravo Z, Orruno M, Parada C, Kaberdin VR, Barcina I, Arana I	Arch Microbiol	10.1007/s00203-016-1200-1	2016	*
Metabolism	Immunogenicity of conserved cork and beta-barrel domains of baumannii acinetobactin utilization protein in an animal model.	Sangroodi YH, Rasooli I, Nazarian S, Ebrahimizadeh W, Sefid F	Turk J Med Sci	10.3906/sag-1407-45	2015	*
Pathogenicity	Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model.	Wei W, Yang H, Hu L, Ye Y, Li J	J Microbiol Immunol Infect	10.1016/j.jmii.2015.10.010	2015	*
Metabolism	Characterization of an Acinetobacter baumannii lptD Deletion Strain: Permeability Defects and Response to Inhibition of Lipopolysaccharide and Fatty Acid Biosynthesis.	Bojkovic J, Richie DL, Six DA, Rath CM, Sawyer WS, Hu Q, Dean CR	J Bacteriol	10.1128/JB.00639-15	2015	*
Enzymology	Prevalence of hypermutators among clinical Acinetobacter baumannii isolates.	Komp Lindgren P, Higgins PG, Seifert H, Cars O	J Antimicrob Chemother	10.1093/jac/dkv378	2015	*
Pathogenicity	Antimicrobial Activity of Gallium Protoporphyrin IX against Acinetobacter baumannii Strains Displaying Different Antibiotic Resistance Phenotypes.	Arivett BA, Fiester SE, Ohneck EJ, Penwell WF, Kaufman CM, Relich RF, Actis LA	Antimicrob Agents Chemother	10.1128/AAC.01472-15	2015	*
Metabolism	Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D.	Stahl J, Bergmann H, Gottig S, Ebersberger I, Averhoff B	PLoS One	10.1371/journal.pone.0138360	2015	*
Metabolism	Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.	Badmasti F, Ajdary S, Bouzari S, Fooladi AA, Shahcheraghi F, Siadat SD	Mol Immunol	10.1016/j.molimm.2015.07.031	2015	*
Metabolism	Phoenix dactylifera (date palm) pit aqueous extract mediated novel route for synthesis high stable silver nanoparticles with high antifungal and antibacterial activity.	Khatami M, Pourseyedi S	IET Nanobiotechnol	10.1049/iet-nbt.2014.0052	2015	*
Pathogenicity	Enhancing pili assembly and biofilm formation in Acinetobacter baumannii ATCC19606 using non-native acyl-homoserine lactones.	Luo LM, Wu LJ, Xiao YL, Zhao D, Chen ZX, Kang M, Zhang Q, Xie Y	BMC Microbiol	10.1186/s12866-015-0397-5	2015	*
Pathogenicity	Simple Method for Markerless Gene Deletion in Multidrug-Resistant Acinetobacter baumannii.	Oh MH, Lee JC, Kim J, Choi CH, Han K	Appl Environ Microbiol	10.1128/AEM.03975-14	2015	*
Pathogenicity	Biofilm Formation and Colistin Susceptibility of Acinetobacter baumannii Isolated from Korean Nosocomial Samples.	Kim HA, Ryu SY, Seo I, Suh SI, Suh MH, Baek WK	Microb Drug Resist	10.1089/mdr.2014.0236	2015	*
Metabolism	Heterologous expression of 3-O-deacylase in Acinetobacter baumannii modulates the endotoxicity of lipopolysaccharide.	Badmasti F, Shahcheraghi F, Siadat SD, Bouzari S, Ajdary S, Amin M, Halabian R, Imani Fooladi AA	J Mol Microbiol Biotechnol	10.1159/000371815	2015	*
Pathogenicity	Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.	Yadav R, Landersdorfer CB, Nation RL, Boyce JD, Bulitta JB	Antimicrob Agents Chemother	10.1128/AAC.04379-14	2015	*
Metabolism	Role of the carboxy terminus of SecA in iron acquisition, protein translocation, and virulence of the bacterial pathogen Acinetobacter baumannii.	Fiester SE, Nwugo CC, Penwell WF, Neary JM, Beckett AC, Arivett BA, Schmidt RE, Geiger SC, Connerly PL, Menke SM, Tomaras AP, Actis LA	Infect Immun	10.1128/IAI.02925-14	2015	*
Pathogenicity	Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.	Garcia-Quintanilla M, Pulido MR, Pachon J, McConnell MJ	PLoS One	10.1371/journal.pone.0114410	2014	*
Enzymology	In vivo activity of daptomycin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.	Yang H, Chen G, Hu L, Liu Y, Cheng J, Li H, Ye Y, Li J	Int J Antimicrob Agents	10.1016/j.ijantimicag.2014.10.012	2014	*
Metabolism	Mutant prevention concentrations of levofloxacin, pazufloxacin and ciprofloxacin for A. baumannii and mutations in gyrA and parC genes.	Sun C, Hao J, Dou M, Gong Y	J Antibiot (Tokyo)	10.1038/ja.2014.150	2014	*
Proteome	Development and characterization of monoclonal antibodies for rapid detection of Acinetobacter baumannii.	Baig A, Cabral TM, Corbett CR	Monoclon Antib Immunodiagn Immunother	10.1089/mab.2013.0073	2014	*
Metabolism	The role of filamentous hemagglutinin adhesin in adherence and biofilm formation in Acinetobacter baumannii ATCC19606(T).	Darvish Alipour Astaneh S, Rasooli I, Mousavi Gargari SL	Microb Pathog	10.1016/j.micpath.2014.07.007	2014	*
Pathogenicity	Recombinant scorpine produced using SUMO fusion partner in Escherichia coli has the activities against clinically isolated bacteria and inhibits the Plasmodium falciparum parasitemia in vitro.	Zhang C, He X, Gu Y, Zhou H, Cao J, Gao Q	PLoS One	10.1371/journal.pone.0103456	2014	*
Pathogenicity	Synergistic effects of ethnomedicinal plants of Apocynaceae family and antibiotics against clinical isolates of Acinetobacter baumannii.	Chusri S, Siriyong T, Na-Phatthalung P, Voravuthikunchai SP	Asian Pac J Trop Med	10.1016/S1995-7645(14)60074-2	2014	*
Pathogenicity	Incubation temperature, osmolarity, and salicylate affect the expression of resistance-nodulation-division efflux pumps and outer membrane porins in Acinetobacter baumannii ATCC19606T.	Bazyleu A, Kumar A	FEMS Microbiol Lett	10.1111/1574-6968.12530	2014	*
Enzymology	Chemical constituents and antimicrobial properties of the essential oil and ethanol extract from the stem of Aglaia odorata Lour.	Joycharat N, Thammavong S, Voravuthikunchai SP, Plodpai P, Mitsuwan W, Limsuwan S, Subhadhirasakul S	Nat Prod Res	10.1080/14786419.2014.924934	2014	*
Enzymology	CpaA a novel protease from Acinetobacter baumannii clinical isolates deregulates blood coagulation.	Tilley D, Law R, Warren S, Samis JA, Kumar A	FEMS Microbiol Lett	10.1111/1574-6968.12496	2014	*
Metabolism	Bactericidal effect of sulbactam against Acinetobacter baumannii ATCC 19606 studied by 2D-DIGE and mass spectrometry.	Lin CH, Su SC, Ho KH, Hsu YW, Lee KR	Int J Antimicrob Agents	10.1016/j.ijantimicag.2014.03.004	2014	*
Enzymology	Pathogenicity of ocular isolates of Acinetobacter baumannii in a mouse model of bacterial endophthalmitis.	Talreja D, Kaye KS, Yu FS, Walia SK, Kumar A	Invest Ophthalmol Vis Sci	10.1167/iovs.13-13401	2014	*
Pathogenicity	Xuebijing Protects Rats from Sepsis Challenged with Acinetobacter baumannii by Promoting Annexin A1 Expression and Inhibiting Proinflammatory Cytokines Secretion.	He XD, Wang Y, Wu Q, Wang HX, Chen ZD, Zheng RS, Wang ZS, Wang JB, Yang Y	Evid Based Complement Alternat Med	10.1155/2013/804940	2013	*
Pathogenicity	Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii.	Beceiro A, Moreno A, Fernandez N, Vallejo JA, Aranda J, Adler B, Harper M, Boyce JD, Bou G	Antimicrob Agents Chemother	10.1128/AAC.01597-13	2013	*
Pathogenicity	Holarrhena antidysenterica as a resistance modifying agent against Acinetobacter baumannii: Its effects on bacterial outer membrane permeability and efflux pumps.	Chusri S, Na-Phatthalung P, Siriyong T, Paosen S, Voravuthikunchai SP	Microbiol Res	10.1016/j.micres.2013.09.004	2013	*
Pathogenicity	Homeostasis of glutathione is associated with polyamine-mediated beta-lactam susceptibility in Acinetobacter baumannii ATCC 19606.	Kwon DH, Hekmaty S, Seecoomar G	Antimicrob Agents Chemother	10.1128/AAC.00692-13	2013	*
Pathogenicity	Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins.	Jun SH, Lee JH, Kim BR, Kim SI, Park TI, Lee JC, Lee YC	PLoS One	10.1371/journal.pone.0071751	2013	*
Metabolism	Functional features of TonB energy transduction systems of Acinetobacter baumannii.	Zimbler DL, Arivett BA, Beckett AC, Menke SM, Actis LA	Infect Immun	10.1128/IAI.00540-13	2013	*
Pathogenicity	In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens.	Phee L, Hornsey M, Wareham DW	Eur J Clin Microbiol Infect Dis	10.1007/s10096-013-1875-z	2013	*
Pathogenicity	In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.	Hornsey M, Phee L, Longshaw C, Wareham DW	Int J Antimicrob Agents	10.1016/j.ijantimicag.2012.11.013	2013	*
Phylogeny	[Changes in expression of gene aba I in biofilm of Acinetobacter baumannii strains isolated from burn patients].	Xiang J, Sun Z, Yang XG, Huan JN	Zhonghua Shao Shang Za Zhi		2012	*
Pathogenicity	In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.	Vidaillac C, Benichou L, Duval RE	Antimicrob Agents Chemother	10.1128/AAC.05996-11	2012	*
Metabolism	The Acinetobacter baumannii entA gene located outside the acinetobactin cluster is critical for siderophore production, iron acquisition and virulence.	Penwell WF, Arivett BA, Actis LA	PLoS One	10.1371/journal.pone.0036493	2012	*
Metabolism	Stress response and virulence functions of the Acinetobacter baumannii NfuA Fe-S scaffold protein.	Zimbler DL, Park TM, Arivett BA, Penwell WF, Greer SM, Woodruff TM, Tierney DL, Actis LA	J Bacteriol	10.1128/JB.00213-12	2012	*
Metabolism	Acinetobacter baumannii outer membrane protein A modulates the biogenesis of outer membrane vesicles.	Moon DC, Choi CH, Lee JH, Choi CW, Kim HY, Park JS, Kim SI, Lee JC	J Microbiol	10.1007/s12275-012-1589-4	2012	*
Pathogenicity	New heterocyclic compounds from 1,2,4-triazole and 1,3,4-thiadiazole class bearing diphenylsulfone moieties. Synthesis, characterization and antimicrobial activity evaluation.	Barbuceanu SF, Saramet G, Almajan GL, Draghici C, Barbuceanu F, Bancescu G	Eur J Med Chem	10.1016/j.ejmech.2012.01.031	2012	*
Pathogenicity	Three-dimensional human skin equivalent as a tool to study Acinetobacter baumannii colonization.	de Breij A, Haisma EM, Rietveld M, El Ghalbzouri A, van den Broek PJ, Dijkshoorn L, Nibbering PH	Antimicrob Agents Chemother	10.1128/AAC.05975-11	2012	*
Pathogenicity	Synergistic activity of coriander oil and conventional antibiotics against Acinetobacter baumannii.	Duarte A, Ferreira S, Silva F, Domingues FC	Phytomedicine	10.1016/j.phymed.2011.11.010	2012	*
Metabolism	Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice.	Gaddy JA, Arivett BA, McConnell MJ, Lopez-Rojas R, Pachon J, Actis LA	Infect Immun	10.1128/IAI.06279-11	2012	*
Pathogenicity	Growth phase-dependent expression of RND efflux pump- and outer membrane porin-encoding genes in Acinetobacter baumannii ATCC 19606.	Fernando D, Kumar A	J Antimicrob Chemother	10.1093/jac/dkr519	2011	*
Pathogenicity	Establishment of a novel target-based real-time quantitative PCR method for Acinetobacter baumannii detection.	Zhang L, Ding G, Wei L, Pan X, Mei L, Zhang Y, Lu Y	Diagn Mol Pathol	10.1097/PDM.0b013e31821bbb1e	2011	*
Pathogenicity	Interaction of Acinetobacter baumannii 19606 and 1656-2 with Acanthamoeba castellanii.	Tamang MD, Kim S, Kim SM, Kong HH, Kim J	J Microbiol	10.1007/s12275-011-1063-8	2011	*
Metabolism	Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-beta-1,6-N-acetylglucosamine.	Henry R, Vithanage N, Harrison P, Seemann T, Coutts S, Moffatt JH, Nation RL, Li J, Harper M, Adler B, Boyce JD	Antimicrob Agents Chemother	10.1128/AAC.05191-11	2011	*
Pathogenicity	Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.	Kuo HY, Chang KC, Kuo JW, Yueh HW, Liou ML	Int J Antimicrob Agents	10.1016/j.ijantimicag.2011.08.016	2011	*
Pathogenicity	[Expressions of pgaABC gene clusters and changes in biofilm phenotype of Acinetobacter baumannii in burn patients].	Xiang J, Sun Z, Song F, Huan JN	Zhonghua Shao Shang Za Zhi		2011	*
Metabolism	Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.	Beceiro A, Llobet E, Aranda J, Bengoechea JA, Doumith M, Hornsey M, Dhanji H, Chart H, Bou G, Livermore DM, Woodford N	Antimicrob Agents Chemother	10.1128/AAC.00079-11	2011	*
Metabolism	Acinetobacter baumannii biofilms: variations among strains and correlations with other cell properties.	McQueary CN, Actis LA	J Microbiol	10.1007/s12275-011-0343-7	2011	*
Metabolism	Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii.	Vashist J, Tiwari V, Das R, Kapil A, Rajeswari MR	Indian J Med Res	IndianJMedRes_2011_133_3_332_78380	2011	*
Metabolism	Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles.	Jin JS, Kwon SO, Moon DC, Gurung M, Lee JH, Kim SI, Lee JC	PLoS One	10.1371/journal.pone.0017027	2011	*
Pathogenicity	Acinetobacter baumannii-induced lung cell death: role of inflammation, oxidative stress and cytosolic calcium.	Smani Y, Docobo-Perez F, McConnell MJ, Pachon J	Microb Pathog	10.1016/j.micpath.2011.01.008	2011	*
Enzymology	Demonstration of an outer membrane protein that is antigenically specific for Acinetobacter baumannii.	Islam AH, Singh KK, Ismail A	Diagn Microbiol Infect Dis	10.1016/j.diagmicrobio.2010.09.008	2011	*
Pathogenicity	Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment.	Soon RL, Nation RL, Cockram S, Moffatt JH, Harper M, Adler B, Boyce JD, Larson I, Li J	J Antimicrob Chemother	10.1093/jac/dkq422	2010	*
Metabolism	Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.	Moffatt JH, Harper M, Harrison P, Hale JD, Vinogradov E, Seemann T, Henry R, Crane B, St Michael F, Cox AD, Adler B, Nation RL, Li J, Boyce JD	Antimicrob Agents Chemother	10.1128/AAC.00834-10	2010	*
Metabolism	Deciphering the iron response in Acinetobacter baumannii: A proteomics approach.	Nwugo CC, Gaddy JA, Zimbler DL, Actis LA	J Proteomics	10.1016/j.jprot.2010.07.010	2010	*
Pathogenicity	In vitro synergistic antibacterial action of certain combinations of gentamicin and essential oils.	Rosato A, Piarulli M, Corbo F, Muraglia M, Carone A, Vitali ME, Vitali C	Curr Med Chem	10.2174/092986710792231996	2010	*
Metabolism	DnaK and GroEL are induced in response to antibiotic and heat shock in Acinetobacter baumannii.	Cardoso K, Gandra RF, Wisniewski ES, Osaku CA, Kadowaki MK, Felipach-Neto V, Haus LFA, Simao RCG	J Med Microbiol	10.1099/jmm.0.020339-0	2010	*
Enzymology	fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.	Dudhani RV, Turnidge JD, Nation RL, Li J	J Antimicrob Chemother	10.1093/jac/dkq226	2010	*
Genetics	Quantitative profiling and identification of outer membrane proteins of beta-lactam resistant strain of Acinetobacter baumannii.	Vashist J, Tiwari V, Kapil A, Rajeswari MR	J Proteome Res	10.1021/pr9011188	2010	*
Metabolism	OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.	Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H	Antimicrob Agents Chemother	10.1128/AAC.00856-09	2009	*
Pathogenicity	Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.	Barbuceanu SF, Almajan GL, Saramet I, Draghici C, Tarcomnicu AI, Bancescu G	Eur J Med Chem	10.1016/j.ejmech.2009.06.021	2009	*
Pathogenicity	CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC19606(T) to human airway epithelial cells and their inflammatory response.	de Breij A, Gaddy J, van der Meer J, Koning R, Koster A, van den Broek P, Actis L, Nibbering P, Dijkshoorn L	Res Microbiol	10.1016/j.resmic.2009.01.002	2009	*
Pathogenicity	The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective.	Fernandez-Reyes M, Rodriguez-Falcon M, Chiva C, Pachon J, Andreu D, Rivas L	Proteomics	10.1002/pmic.200800434	2009	*
Enzymology	Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme.	Wisplinghoff H, Hippler C, Bartual SG, Haefs C, Stefanik D, Higgins PG, Seifert H	Clin Microbiol Infect	10.1111/j.1469-0691.2008.02010.x	2008	*
Pathogenicity	In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates.	Owen RJ, Li J, Nation RL, Spelman D	J Antimicrob Chemother	10.1093/jac/dkl512	2007	*
Pathogenicity	Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.	Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L	Antimicrob Agents Chemother	10.1128/AAC.00103-06	2006	*
Phylogeny	Genomic species identification of Acinetobacter of clinical isolates by 16S rDNA sequencing.	Misbah S, Hassan H, Yusof MY, Hanifah YA, AbuBakar S	Singapore Med J		2005	*
Metabolism	The siderophore-mediated iron acquisition systems of Acinetobacter baumannii ATCC 19606 and Vibrio anguillarum 775 are structurally and functionally related.	Dorsey CW, Tomaras AP, Connerly PL, Tolmasky ME, Crosa JH, Actis LA	Microbiology (Reading)	10.1099/mic.0.27371-0	2004	*
Metabolism	Identification and transcriptional organization of a gene cluster involved in biosynthesis and transport of acinetobactin, a siderophore produced by Acinetobacter baumannii ATCC 19606T.	Mihara K, Tanabe T, Yamakawa Y, Funahashi T, Nakao H, Narimatsu S, Yamamoto S	Microbiology (Reading)	10.1099/mic.0.27141-0	2004	*
Genetics	The structure of the carbohydrate backbone of the lipopolysaccharide from Acinetobacter baumannii strain ATCC 19606.	Vinogradov EV, Duus JO, Brade H, Holst O	Eur J Biochem	10.1046/j.0014-2956.2001.02647.x	2002	*
Metabolism	Monoclonal antibodies against the iron regulated outer membrane Proteins of Acinetobacter baumannii are bactericidal.	Goel VK, Kapil A	BMC Microbiol	10.1186/1471-2180-1-16	2001	*
Pathogenicity	Bactericidal and bacteriostatic activity of gemifloxacin against Acinetobacter spp. in vitro.	Higgins PG, Coleman K, Amyes SG	J Antimicrob Chemother	10.1093/jac/45.suppl_3.71	2000	*
Enzymology	Cloning and characterization of 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) transferase genes (kdtA) from Acinetobacter baumannii and Acinetobacter haemolyticus.	Bode CE, Brabetz W, Brade H	Eur J Biochem	10.1046/j.1432-1327.1998.2540404.x	1998	*
Enzymology	Cloning and expression in Escherichia coli of the gene encoding a novel L-2,4-diaminobutyrate decarboxylase of Acinetobacter baumannii.	Ikai H, Yamamoto S	FEMS Microbiol Lett	10.1016/0378-1097(94)90253-4	1994	*
Phylogeny	Isolation and structure elucidation of acinetobactin, a novel siderophore from Acinetobacter baumannii.	Yamamoto S, Okujo N, Sakakibara Y	Arch Microbiol	10.1007/BF00301846	1994	*
Enzymology	Immunobiology of Acinetobacter baumannii and genospecies 3.	Traub WH, Bauer D	Zentralbl Bakteriol	10.1016/s0934-8840(11)80403-2	1993	*
Transcriptome	Transcriptome Analysis of Acinetobacter baumannii in Rapid Response to Subinhibitory Concentration of Minocycline.	Gao L, Ma X	Int J Environ Res Public Health	10.3390/ijerph192316095	2022	*
Phylogeny	Analysis of virulence proteins in pathogenic Acinetobacter baumannii to provide early warning of zoonotic risk.	Zou D, Chang J, Lu S, Xu J, Hu P, Zhang K, Sun X, Guo W, Li Y, Liu Z, Ren H	Microbiol Res	10.1016/j.micres.2022.127222	2022	*
Phylogeny	Molecular Characterization of Bacterial Isolates from Soil Samples and Evaluation of their Antibacterial Potential against MDRS.	Sadiqi S, Hamza M, Ali F, Alam S, Shakeela Q, Ahmed S, Ayaz A, Ali S, Saqib S, Ullah F, Zaman W	Molecules	10.3390/molecules27196281	2022	*
Metabolism	Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability.	Stracquadanio S, Bonomo C, Marino A, Bongiorno D, Privitera GF, Bivona DA, Mirabile A, Bonacci PG, Stefani S	Microbiol Spectr	10.1128/spectrum.02347-22	2022	*
Transcriptome	Transcriptomic analysis reveals the regulatory role of quorum sensing in the Acinetobacter baumannii ATCC 19606 via RNA-seq.	Xiong L, Yi F, Yu Q, Huang X, Ao K, Wang Y, Xie Y	BMC Microbiol	10.1186/s12866-022-02612-z	2022	*
Pathogenicity	Profiling Antibiotic Resistance in Acinetobacter calcoaceticus.	Glover JS, Ticer TD, Engevik MA	Antibiotics (Basel)	10.3390/antibiotics11070978	2022	*
Pathogenicity	Synthesis and biological evaluation of antibacterial activity of novel clarithromycin derivatives incorporating 1,2,3-triazole moieties at the 4''- and 11-OH positions.	Qin Y, Sun M, Zhang N, Yang Y, Ma P	Bioorg Chem	10.1016/j.bioorg.2022.106020	2022	*
Genetics	Genome Sequence and Characterization of Acinetobacter Phage DMU1.	Pehde BM, Niewohner D, Keomanivong FE, Carruthers MD	Phage (New Rochelle)	10.1089/phage.2020.0043	2021	*
	Overexpression of BIT33_RS14560 Enhances the Biofilm Formation and Virulence of Acinetobacter baumannii.	Yang R, Lai B, Liao K, Liu B, Huang L, Li S, Gu J, Lin Z, Chen Y, Wang S, Qiu Y, Deng J, Chen S, Zhuo C, Zhou Y	Front Microbiol	10.3389/fmicb.2022.867770	2022	*
	Ketoprofen, piroxicam and indomethacin-suppressed quorum sensing and virulence factors in Acinetobacter baumannii.	Elshaer SL, Shaldam MA, Shaaban MI	J Appl Microbiol	10.1111/jam.15609	2022	*
	Mechanisms Underlying Synergistic Killing of Polymyxin B in Combination with Cannabidiol against Acinetobacter baumannii: A Metabolomic Study.	Hussein M, Allobawi R, Levou I, Blaskovich MAT, Rao GG, Li J, Velkov T	Pharmaceutics	10.3390/pharmaceutics14040786	2022	*
	Immunity induced by valine-glycine repeat protein G imparts histoprotection of vital body organs against Acinetobacter baumannii.	Alipouri S, Rasooli I, Ghaini MH, Jahangiri A, Darvish Alipour Astaneh S, Ramezanalizadeh F	J Genet Eng Biotechnol	10.1186/s43141-022-00325-4	2022	*
	Inhibition of AdeB, AceI, and AmvA Efflux Pumps Restores Chlorhexidine and Benzalkonium Susceptibility in Acinetobacter baumannii ATCC 19606.	Migliaccio A, Esposito EP, Bagattini M, Berisio R, Triassi M, De Gregorio E, Zarrilli R	Front Microbiol	10.3389/fmicb.2021.790263	2022	*
	The Involvement of the csy1 Gene in the Antimicrobial Resistance of Acinetobacter baumannii.	Guo T, Sun X, Li M, Wang Y, Jiao H, Li G	Front Med (Lausanne)	10.3389/fmed.2022.797104	2022	*
	Ciprofloxacin-Tethered 1,2,3-Triazole Conjugates: New Quinolone Family Compounds to Upgrade Our Antiquated Approach against Bacterial Infections.	Agarwal A, Singh P, Maurya A, Patel UK, Singh A, Nath G	ACS Omega	10.1021/acsomega.1c05303	2022	*
	Histopathological Analysis of Acinetobacter baumannii Lung Infection in a Mouse Model.	Tansho-Nagakawa S, Sato Y, Ubagai T, Kikuchi-Ueda T, Kamoshida GO, Nishida S, Ono Y	Pol J Microbiol	10.33073/pjm-2021-044	2021	*
	Subinhibitory Concentrations of Clinically-Relevant Antimicrobials Affect Resistance-Nodulation-Division Family Promoter Activity in Acinetobacter baumannii.	Prieto Martin Gil S, Tajuelo A, Lopez-Siles M, McConnell MJ	Front Microbiol	10.3389/fmicb.2021.780201	2021	*
	Anti-Omp34 antibodies protect against Acinetobacter baumannii in a murine sepsis model.	Naghipour Erami A, Rasooli I, Jahangiri A, Darvish Alipour Astaneh S	Microb Pathog	10.1016/j.micpath.2021.105291	2021	*
	Combination of AgNPs and Domiphen is Antimicrobial Against Biofilms of Common Pathogens.	Hu L, Yang X, Yin J, Rong X, Huang X, Yu P, He Z, Liu Y	Int J Nanomedicine	10.2147/IJN.S334133	2021	*
	Effect of Subinhibitory Concentrations of Antibiotics and Disinfectants on ISAba-Mediated Inactivation of Lipooligosaccharide Biosynthesis Genes in Acinetobacter baumannii.	Olmeda-Lopez H, Corral-Lugo A, McConnell MJ	Antibiotics (Basel)	10.3390/antibiotics10101259	2021	*
	Antibiofilm action of Persea americana glycolic extract over Acinetobacter baumannii and absence of toxicity in Galleria mellonella.	Dos Santos Liberato SF, da Cruz Vegian MR, Abu Hasna A, de Alvarenga JA, Dos Santos JG, Tini IRP, Amendola I, Junqueira JC, de Oliveira LD	J Complement Integr Med	10.1515/jcim-2021-0051	2021	*
	Regulation of tert-Butyl Hydroperoxide Resistance by Chromosomal OhrR in A. baumannii ATCC 19606.	Chen SJ, Shu HY, Lin GH	Microorganisms	10.3390/microorganisms9030629	2021	*
	Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters.	Foong WE, Wilhelm J, Tam HK, Pos KM	J Antimicrob Chemother	10.1093/jac/dkaa015	2020	*
	A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection.	Pulido MR, Garcia-Quintanilla M, Pachon J, McConnell MJ	Vaccine	10.1016/j.vaccine.2019.11.043	2019	*
	Combined Effects Of Low Incubation Temperature, Minimal Growth Medium, And Low Hydrodynamics Optimize Acinetobacter baumannii Biofilm Formation.	Eze EC, El Zowalaty ME	Infect Drug Resist	10.2147/IDR.S203919	2019	*
	Computational screening of antimicrobial peptides for Acinetobacter baumannii.	Majumder A, Biswal MR, Prakash MK	PLoS One	10.1371/journal.pone.0219693	2019	*
	Efficacy of Poloxamer-Based Wound Dressings on Acinetobacter baumanni Biofilms.	Salisbury AM, Mullin M, Chen R, Percival SL	Adv Wound Care (New Rochelle)	10.1089/wound.2018.0854	2019	*
	Metabolic Responses to Polymyxin Treatment in Acinetobacter baumannii ATCC 19606: Integrating Transcriptomics and Metabolomics with Genome-Scale Metabolic Modeling.	Zhu Y, Zhao J, Maifiah MHM, Velkov T, Schreiber F, Li J	mSystems	10.1128/mSystems.00157-18	2019	*
	Synergism of fused bicyclic 2-aminothiazolyl compounds with polymyxin B against Klebsiella pneumoniae.	Wang R, Hou S, Dong X, Chen D, Shao L, Qian L, Li Z, Xu X	Medchemcomm	10.1039/c7md00354d	2017	*
	LpxK Is Essential for Growth of Acinetobacter baumannii ATCC 19606: Relationship to Toxic Accumulation of Lipid A Pathway Intermediates.	Wei JR, Richie DL, Mostafavi M, Metzger LE 4th, Rath CM, Sawyer WS, Takeoka KT, Dean CR	mSphere	10.1128/mSphere.00199-17	2017	*
	Antimicrobial effects of Ferula gummosa Boiss gum against extended-spectrum beta-lactamase producing Acinetobacter clinical isolates.	Afshar FF, Saffarian P, Hosseini HM, Sattarian F, Amin M, Fooladi AA	Iran J Microbiol		2016	*
	Antibacterial Low Molecular Weight Cationic Polymers: Dissecting the Contribution of Hydrophobicity, Chain Length and Charge to Activity.	Grace JL, Huang JX, Cheah SE, Truong NP, Cooper MA, Li J, Davis TP, Quinn JF, Velkov T, Whittaker MR	RSC Adv	10.1039/C5RA24361K	2016	*
	Genotypic and Antimicrobial Susceptibility of Carbapenem-resistant Acinetobacter baumannii: Analysis of is Aba Elements and bla OXA-23-like Genes Including a New Variant.	Bahador A, Raoofian R, Pourakbari B, Taheri M, Hashemizadeh Z, Hashemi FB	Front Microbiol	10.3389/fmicb.2015.01249	2015	*
	Optimisation of the Caenorhabditis elegans model for studying the pathogenesis of opportunistic Acinetobacter baumannii.	Vallejo JA, Beceiro A, Rumbo-Feal S, Rodriguez-Palero MJ, Russo TA, Bou G	Int J Antimicrob Agents	10.1016/j.ijantimicag.2015.05.021	2015	*
	Draft Genome Assembly of Acinetobacter baumannii ATCC 19606.	Davenport KW, Daligault HE, Minogue TD, Bruce DC, Chain PS, Coyne SR, Jaissle JG, Koroleva GI, Ladner JT, Li PE, Palacios GF, Scholz MB, Teshima H, Johnson SL	Genome Announc	10.1128/genomeA.00832-14	2014	*
	Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3.	Ketter PM, Guentzel MN, Schaffer B, Herzig M, Wu X, Montgomery RK, Parida BK, Fedyk CG, Yu JJ, Jorgensen J, Chambers JP, Cap AP, Arulanandam BP	Infect Immun	10.1128/IAI.01958-14	2014	*
	Cryo-electron tomography analysis of membrane vesicles from Acinetobacter baumannii ATCC19606 T.	Koning RI, de Breij A, Oostergetel GT, Nibbering PH, Koster AJ, Dijkshoorn L	Res Microbiol	10.1016/j.resmic.2013.02.007	2013	*
	Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.	McConnell MJ, Rumbo C, Bou G, Pachon J	Vaccine	10.1016/j.vaccine.2011.06.001	2011	*
	Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis.	Cirioni O, Silvestri C, Ghiselli R, Orlando F, Riva A, Gabrielli E, Mocchegiani F, Cianforlini N, Trombettoni MM, Saba V, Scalise G, Giacometti A	Crit Care Med	10.1097/CCM.0b013e31819c3e22	2009	*
	A novel pentavalent vaccine candidate completely protects against Acinetobacter baumannii in a mouse model of peritonitis.	Hagag YA, Said HS, Kenawy HI, Hassan R	Appl Microbiol Biotechnol	10.1007/s00253-022-12231-3	2022	*
	Chitosan-Placental ECM Composite Thermos-Responsive Hydrogel as a Biomimetic Wound Dressing with Angiogenic Property.	Azadbakht A, Alizadeh S, Aliakbar Ahovan Z, Khosrowpour Z, Majidi M, Pakzad S, Shojaei S, Chauhan NPS, Jafari M, Gholipourmalekabadi M	Macromol Biosci	10.1002/mabi.202200386	2022	*
	Cinnamaldehyde derivatives act as antimicrobial agents against Acinetobacter baumannii through the inhibition of cell division.	Chai WC, Whittall JJ, Polyak SW, Foo K, Li X, Dutschke CJ, Ogunniyi AD, Ma S, Sykes MJ, Semple SJ, Venter H	Front Microbiol	10.3389/fmicb.2022.967949	2022	*

References

#9084

Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 30007

#20215

Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )

#20218

Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 )

#42141 ; Curators of the CIP;

#66792

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#67770 Japan Collection of Microorganism (JCM) ; Curators of the JCM;

#68369

Automatically annotated from API 20NE .

#68371

Automatically annotated from API 50CH acid .

#68382

Automatically annotated from API zym .

#69479

João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta .

#69480

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#69481

Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch: Predictions based on the model GenomeNet Sporulation v. 1 . ( DOI 10.21203/rs.3.rs-2527258/v1 )

#77520

Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.: StrainInfo: A central database for resolving microbial strain identifiers . ( DOI 10.60712/SI-ID92085.1 )

#116742 Collection of Institut Pasteur ; Curators of the CIP; CIP 70.34
* These data were automatically processed and therefore are not curated

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Search for species Acinetobacter baumannii in external resources:
SILVA
BRENDA
PANGAEA
StrainInfo
GBIF

Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841

Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841 ATCC 19606

Change proposal

Change proposal